Related references
Note: Only part of the references are listed.Endoglin Promotes Transforming Growth Factor β-mediated Smad 1/5/8 Signaling and Inhibits Endothelial Cell Migration through Its Association with GIPC
Nam Y. Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Endoglin-mediated vascular remodeling: Mechanisms underlying hereditary hemorrhagic telangiectasia
Franck Lebrin et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2008)
Activin receptor-like kinase 1 inhibits human microvascular endothelial cell migration: Potential roles for JNK and ERK kinase
Laurent David et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
The interaction of endoglin with β-arrestin2 regulates transforming growth factor-β-mediated ERK activation and migration in endothelial cells
Nam Y. Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in prostatic adenocarcinoma
Yasser M. El-Gohary et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2007)
BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis
Marion Scharpfenecker et al.
JOURNAL OF CELL SCIENCE (2007)
Vascular endothelial growth factor and endoglin (CD-105) in gastric cancer
Nikolaos I. Nikiteas et al.
GASTRIC CANCER (2007)
High expressions of CD105 and VEGF in early oral cancer predict potential cervical metastasis
Chih-Yen Chien et al.
JOURNAL OF SURGICAL ONCOLOGY (2006)
Endoglin structure and function -: Determinants of endoglin phosphorylation by transforming growth factor-β receptors
Rositsa I. Koleva et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Comparative evaluation of microvessel density determined by CD34 or CD105 in benign and malignant gastric lesions
Shigang Ding et al.
HUMAN PATHOLOGY (2006)
High expression of CD105 as a prognostic predictor of early tongue cancer
Hui-Ching Chuang et al.
LARYNGOSCOPE (2006)
Endoglin expression is associated with poor oncologic outcome in oral and oropharyngeal carcinoma
Gino Marioni et al.
ACTA OTO-LARYNGOLOGICA (2006)
Correlation between CD105 expression and postoperative recurrence and metastasis of hepatocellular carcinoma
Lian-Yue Yang et al.
BMC CANCER (2006)
Interaction and functional interplay between endoglin and ALK-1, two components of the endothelial transforming growth factor-β receptor complex
FJ Blanco et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2005)
Endoglin null endothelial cells proliferate faster and are more responsive to transforming growth factor β1 with higher affinity receptors and an activated Alk1 pathway
N Pece-Barbara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in colorectal cancer
RS Saad et al.
MODERN PATHOLOGY (2004)
Endoglin regulates cytoskeletal organization through binding to ZRP-1, a member of the Lim family of proteins
F Sanz-Rodriguez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Endoglin controls cell migration and composition of focal adhesions -: Function of the cytosolic domain
BA Conley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Endoglin promotes endothelial cell proliferation and TGF-β/ALK1 signal transduction
F Lebrin et al.
EMBO JOURNAL (2004)
Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFP/ALK5 signaling
MJ Goumans et al.
MOLECULAR CELL (2003)
Controlling the angiogenic switch -: A balance between two distinct TGF-β receptor signaling pathways
MJ Goumans et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2003)
CD105 is important for angiogenesis: evidence and potential applications
SE Duff et al.
FASEB JOURNAL (2003)
Activin receptor-like kinase 1 is implicated in the maturation phase of angiogenesis
S Lamouille et al.
BLOOD (2002)
Extracellular and cytoplasmic domains of endoglin interact with the transforming growth factor-β receptors I and II
M Guerrero-Esteo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
SB-431542 is a potent and specific inhibitor of transforming growth factor-β superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7
GJ Inman et al.
MOLECULAR PHARMACOLOGY (2002)
Estimation of angiogenesis with anti-CD105 immunostaining in the process of colorectal cancer development
K Akagi et al.
SURGERY (2002)
Share Paper
